Avastin News
Most Popular Avastin Story
Avastin studies point to benefits in early breast cancer
Does Avastin deserve another look from regulators? Avastin lost its FDA approval for late-stage breast cancer last year after a contentious review, but now two new studies show that it might help Read more...
Latest Headlines
- February 1, 2012
- January 26, 2012
- January 3, 2012
- December 23, 2011
- December 9, 2011
- December 5, 2011
- December 1, 2011
- November 29, 2011
- November 28, 2011
- November 21, 2011
- November 18, 2011
- October 27, 2011
- October 25, 2011
- October 14, 2011
- October 5, 2011
- October 3, 2011
- September 22, 2011
- September 7, 2011
- September 6, 2011
- September 2, 2011
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
